Literature DB >> 18066610

A high activity index of stearoyl-CoA desaturase is associated with increased risk of fracture in men.

H Melhus1, U Risérus, E Warensjö, L Wernroth, K Jensevik, L Berglund, B Vessby, K Michaëlsson.   

Abstract

UNLABELLED: The activity index of stearoyl-CoA desaturase (SCD), a key enzyme in lipogenesis, was associated with increased risk of fracture in a longitudinal population-based cohort of men. This indicates that elevated levels of endogenous lipogenesis increase the risk of fracture and suggest a role for saturated fat in the pathogenesis of osteoporosis.
INTRODUCTION: Osteoblasts and marrow adipocytes are derived from a common mesenchymal progenitor, and experimental studies have indicated that increased adipogenesis can occur at the expense of osteoblasts, leading to bone loss. Stearoyl-CoA desaturase (SCD) converts saturated to monounsaturated fatty acids and is a key enzyme in lipogenesis.
METHODS: Analysis was performed in a population-based, longitudinal cohort study of men (n = 2009). A product-to-precursor index (palmitoleic acid/palmitic acid) was used to estimate SCD activity in fasting serum analyzed in samples obtained at enrollment at age 50 years. Fractures were documented in 422 men during 35 years of follow-up. Cox regression analysis was used to determine the risk of fracture according to SCD activity index.
RESULTS: The risk of fracture was highest among men with the highest levels of SCD activity index. Multivariable analysis of the risk of fracture in the highest quintile as compared to the lowest one showed that the rate ratio was 1.71 (95% CI 1.26-2.33) for any fracture, with an estimated population attributable risk of 15%. The risk was further increased within the highest quintile.
CONCLUSIONS: Our results indicate that elevated levels of endogenous lipogenesis increase the risk of fracture and suggest a role for saturated fat in the pathogenesis of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066610      PMCID: PMC2440922          DOI: 10.1007/s00198-007-0521-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  35 in total

1.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

2.  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.

Authors:  Alan D Attie; Ronald M Krauss; Mark P Gray-Keller; Alison Brownlie; Makoto Miyazaki; John J Kastelein; Aldons J Lusis; Anton F H Stalenhoef; Jonathan P Stoehr; Michael R Hayden; James M Ntambi
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

3.  Thiazolidinedione use and bone loss in older diabetic adults.

Authors:  Ann V Schwartz; Deborah E Sellmeyer; Eric Vittinghoff; Lisa Palermo; Beata Lecka-Czernik; Kenneth R Feingold; Elsa S Strotmeyer; Helaine E Resnick; Laura Carbone; Brock A Beamer; Seok Won Park; Nancy E Lane; Tamara B Harris; Steven R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

4.  Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later.

Authors:  J Sundström; L Lind; B Vessby; B Andrén; A Aro; H Lithell
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

5.  Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins.

Authors:  Marie Kunesová; Vojtech Hainer; Eva Tvrzicka; Stephen D Phinney; Vladimir Stich; Jana Parízková; Ales Zák; Albert J Stunkard
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

6.  Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.

Authors:  James M Ntambi; Makoto Miyazaki; Jonathan P Stoehr; Hong Lan; Christina M Kendziorski; Brian S Yandell; Yang Song; Paul Cohen; Jeffrey M Friedman; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

7.  Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX.

Authors:  J Cabrera-Abreu; N J Crabtree; E Elias; W Fraser; R Cramb; S Alger
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

8.  Serum retinol levels and the risk of fracture.

Authors:  Karl Michaëlsson; Hans Lithell; Bengt Vessby; Håkan Melhus
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

9.  Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control.

Authors:  Bernd Schwahn; Frank Rauch; Udo Wendel; Eckhard Schönau
Journal:  J Pediatr       Date:  2002-09       Impact factor: 4.406

10.  Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study.

Authors:  J P Rake; G Visser; D Huismans; S Huitema; E van der Veer; D A Piers; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

View more
  2 in total

Review 1.  The effect of antiresorptives on bone quality.

Authors:  Robert R Recker; Laura Armas
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

2.  Alterations in DNA methylation profiles in cancellous bone of postmenopausal women with osteoporosis.

Authors:  Yu Zhou; Ling Yang; Hong Wang; Xi Chen; Wei Jiang; Zhicong Wang; Shuping Liu; Yuehong Liu
Journal:  FEBS Open Bio       Date:  2020-06-26       Impact factor: 2.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.